DHI Capex To Revenue from 2010 to 2025

DHI Stock  USD 140.05  0.23  0.16%   
DR Horton's Capex To Revenue is decreasing with slightly volatile movements from year to year. Capex To Revenue is estimated to finish at 0.01 this year. Capex To Revenue is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. View All Fundamentals
 
Capex To Revenue  
First Reported
2010-12-31
Previous Quarter
0.00483481
Current Value
0.005031
Quarterly Volatility
0.00341531
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check DR Horton financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DR Horton's main balance sheet or income statement drivers, such as Depreciation And Amortization of 105.2 M, Interest Expense of 163 M or Selling General Administrative of 4.3 B, as well as many indicators such as Price To Sales Ratio of 6.47, Dividend Yield of 0.0133 or PTB Ratio of 48.67. DHI financial statements analysis is a perfect complement when working with DR Horton Valuation or Volatility modules.
  
Check out the analysis of DR Horton Correlation against competitors.
For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.

Latest DR Horton's Capex To Revenue Growth Pattern

Below is the plot of the Capex To Revenue of DR Horton over the last few years. It is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. DR Horton's Capex To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DR Horton's overall financial position and show how it may be relating to other accounts over time.
Capex To Revenue10 Years Trend
Slightly volatile
   Capex To Revenue   
       Timeline  

DHI Capex To Revenue Regression Statistics

Arithmetic Mean0.01
Geometric Mean0.01
Coefficient Of Variation43.90
Mean Deviation0
Median0.01
Standard Deviation0
Sample Variance0.000012
Range0.0099
R-Value(0.37)
Mean Square Error0.000011
R-Squared0.14
Significance0.15
Slope(0.0003)
Total Sum of Squares0.0002

DHI Capex To Revenue History

2025 0.005031
2024 0.004835
2023 0.004492
2022 0.004191
2021 0.004427
2020 0.009628
2019 0.0141

About DR Horton Financial Statements

Investors use fundamental indicators, such as DR Horton's Capex To Revenue, to determine how well the company is positioned to perform in the future. Although DR Horton's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Capex To Revenue 0.00  0.01 

Currently Active Assets on Macroaxis

When determining whether DR Horton offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DR Horton's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Horton Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Horton Stock:
Check out the analysis of DR Horton Correlation against competitors.
For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Household Durables space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DR Horton. If investors know DHI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DR Horton listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.12)
Dividend Share
1.2
Earnings Share
14.35
Revenue Per Share
111.689
Quarterly Revenue Growth
(0.05)
The market value of DR Horton is measured differently than its book value, which is the value of DHI that is recorded on the company's balance sheet. Investors also form their own opinion of DR Horton's value that differs from its market value or its book value, called intrinsic value, which is DR Horton's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DR Horton's market value can be influenced by many factors that don't directly affect DR Horton's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DR Horton's value and its price as these two are different measures arrived at by different means. Investors typically determine if DR Horton is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DR Horton's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.